Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight gain, eating patterns, and body composition during initiation of basal insulin therapy (insulin detemir vs insulin glargine)
2007-000353-65Phase 4Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Change in hepatic fat content. Started Aug 2007; status: terminated.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-000353-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000353-65.